STANAG 2571
STANAG 2571 minimum laboratory test requirements for medical facilities
NATO nations and defence health planners resourcing laboratory capability for in-theatre medical treatment facilities
STANAG 2571 is the NATO agreement by which member nations commit to implement AMedP-8.5's minimum laboratory test requirements for in-theatre military medical treatment facilities.
- Edition
- 2
- Published
- 2023-06-27
What it is
The agreement, not the test list
STANAG 2571 is a NATO Standardization Agreement: the mechanism by which member nations commit to implement a named technical publication, here AMedP-8.5. The STANAG itself carries no test list. Its aim is a description of the minimal laboratory capabilities needed at Roles 1 to 3 to contribute medical care during deployment, with the per-role test requirements standardized in AMedP-8.5's own tables. Anyone looking for the tests a Role 1, 2 or 3 laboratory unit has to be able to run needs AMedP-8.5, not this cover.
What nations agree to
Participating nations agree to implement AMedP-8.5, Edition B. This Edition 2 of STANAG 2571 supersedes Edition 1, dated 30 October 2013; compared with that edition, the AMedP-8.5 it now covers also provides laboratory requirements for Role 1 and Role 2F capabilities, extending the earlier coverage. No NATO Effective Date applies to this STANAG.
How it binds
A STANAG binds a nation, not a supplier, directly. Nations examine their own ratification and advise the NATO Standardization Office of their intention; once implemented, Allies and NATO bodies report implementation details through NATO's electronic reporting tool, and partner nations are invited to do the same. For an organisation resourcing or running an in-theatre laboratory unit, the requirement arrives when a contract or a national tasking cites AMedP-8.5, not from the STANAG's existence on its own.
Related documents on the cover
The cover lists several other NATO documents as related reading rather than binding requirements: MC 0326 (NATO Principles and Policies of Medical Support), STANAG 2228 (covering AJP-4.10, Allied Joint Doctrine for Medical Support), STANAG 2517 (covering AMedP-5.3, development and implementation of telemedicine systems), STANAG 2543 (covering AMedP-5.2, data interchange between health information systems), STANAG 2348 (covering AMedP-8.2, the basic military medical record), and STANAG 2132 (covering AMedP-8.1, documentation relative to initial medical treatment and evacuation).
Review and tasking authority
STANAG 2571 is reviewed in accordance with AAP-03, with the result of each review recorded in NATO's Standardization Document Database. It is supervised under NATO's medical standardization structure: COMEDS, MCMedSB, MedStd and MHC.
How we help
STANAG 2571 does not give an organisation anything to implement directly: it is the agreement that commits nations to AMedP-8.5, and the laboratory test requirements a Role 1, 2 or 3 facility has to meet live in that publication, not in this cover. The work itself is clinical and technical - staffing and equipping a laboratory unit to the standard AMedP-8.5 sets for its Role, and running the tests it lists. ComplyTrain does not perform that testing and does not verify a laboratory unit's technical output.
What ComplyTrain supports is the evidence trail around it once AMedP-8.5 is cited in a contract or a national tasking: the procedures that define how a deployed laboratory unit is resourced and staffed for its Role, the training records for the people running it, and the documentation showing which edition of AMedP-8.5 a facility was built against. It does not decide which Role level applies to a deployment, and it does not substitute for the laboratory competence the work demands.
Which Role's requirements apply, and what else a defence health contract pulls in alongside them, is set by the contract and the customer's quality clause. The standards explorer shows what sits alongside STANAG 2571 and AMedP-8.5; talk to us about the documentation and training-record side of meeting it.
Standards it references
- STANAG 2228Background
- STANAG 2517Background
- AMedP-5.3Background
- STANAG 2543Background
- AMedP-5.2Background
- STANAG 2348Background
- AMedP-8.2Background
- STANAG 2132Background
- AMedP-8.1Background
Questions
Is STANAG 2571 mandatory?
Only through a contract or a national tasking. A STANAG binds the nations that ratify it, and each nation implements it through its own regulations; a supplier meets it because a tender or a contract cites AMedP-8.5, not because the STANAG exists.
What is the difference between STANAG 2571 and AMedP-8.5?
STANAG 2571 is the agreement: the short cover by which nations commit to implement a publication. AMedP-8.5 is that publication, and it is where the minimum laboratory test requirements for each Role are actually set out.
Which edition of AMedP-8.5 does STANAG 2571 cover?
This Edition 2 of STANAG 2571, dated 27 June 2023, covers AMedP-8.5, Edition B. It supersedes STANAG 2571, Edition 1, dated 30 October 2013.
Can ComplyTrain certify us against STANAG 2571?
No. The cover names no certification scheme, and NATO does not award certification against a STANAG. ComplyTrain supports the documentation and training records around meeting AMedP-8.5's requirements; it does not issue or substitute for any assessment.
What laboratory capability does STANAG 2571 cover?
A description of the minimal laboratory capabilities needed at Roles 1 to 3 to contribute medical care during deployment. The per-role test requirements themselves are standardized in AMedP-8.5's tables, not in this STANAG.